Literature DB >> 15208271

A genetic basis for the "Adonis" phenotype of low adiposity and strong bones.

Geoffrey B Johnson1, B Lawrence Riggs, Jeffrey L Platt.   

Abstract

Toll receptors in Drosophila contribute to host defense and establish the body plan. Mammalian homologues of Toll, the Toll-like receptors (TLRs), are thought to function only in host defense. Here, we report that mice harboring mutations in TLR4 or in CD14, a co-receptor for TLR4, have an "ideal" body plan consisting of increased bone mineral content, density, and size as well as decreased body fat. These mutant mice live long lives, have normal activity and fertility, and show no evidence of infection. Unlike many strains of caged wild-type mice, they do not become obese. Although all mice continue to gain body fat, bone content, and overall weight, the difference in bone content and body fat between mutant and wild-type mice increases with age. Thus, defects in TLR4/CD14 complex generate an "Adonis" phenotype, characterized by this ideal body type, and this function could potentially be exploited for the treatment of osteoporosis and obesity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15208271     DOI: 10.1096/fj.04-1572fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  25 in total

Review 1.  Gut microbiota: a new path to treat obesity.

Authors:  Giovanna Muscogiuri; Elena Cantone; Sara Cassarano; Dario Tuccinardi; Luigi Barrea; Silvia Savastano; Annamaria Colao
Journal:  Int J Obes Suppl       Date:  2019-04-12

2.  Saturated fatty acids enhance osteoclast survival.

Authors:  So-Ra Oh; Ok-Joo Sul; Youn-Young Kim; Hye-Jin Kim; Rina Yu; Jae-Hee Suh; Hye-Seon Choi
Journal:  J Lipid Res       Date:  2010-05       Impact factor: 5.922

3.  Balanced translocation in a patient with craniosynostosis disrupts the SOX6 gene and an evolutionarily conserved non-transcribed region.

Authors:  A Tagariello; R Heller; A Greven; V M Kalscheuer; T Molter; A Rauch; W Kress; A Winterpacht
Journal:  J Med Genet       Date:  2005-10-28       Impact factor: 6.318

4.  Toll-like receptor 4 D299G polymorphism in metabolic disorders: a meta-analysis.

Authors:  F S Belforte; F Coluccio Leskow; E Poskus; A Penas Steinhardt
Journal:  Mol Biol Rep       Date:  2012-12-29       Impact factor: 2.316

5.  Soluble CD14: genomewide association analysis and relationship to cardiovascular risk and mortality in older adults.

Authors:  Alex P Reiner; Ethan M Lange; Nancy S Jenny; Paulo H M Chaves; Jaclyn Ellis; Jin Li; Jeremy Walston; Leslie A Lange; Mary Cushman; Russell P Tracy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11-15       Impact factor: 8.311

6.  Soluble CD14 and fracture risk.

Authors:  M Bethel; P Bůžková; H A Fink; J A Robbins; J A Cauley; J Lee; J I Barzilay; D I Jalal; L D Carbone
Journal:  Osteoporos Int       Date:  2015-12-11       Impact factor: 4.507

7.  The free fatty acid receptor G protein-coupled receptor 40 (GPR40) protects from bone loss through inhibition of osteoclast differentiation.

Authors:  Fabien Wauquier; Claire Philippe; Laurent Léotoing; Sylvie Mercier; Marie-Jeanne Davicco; Patrice Lebecque; Jérôme Guicheux; Paul Pilet; Elisabeth Miot-Noirault; Vincent Poitout; Thierry Alquier; Véronique Coxam; Yohann Wittrant
Journal:  J Biol Chem       Date:  2013-01-18       Impact factor: 5.157

8.  Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle.

Authors:  M S Radin; S Sinha; B A Bhatt; N Dedousis; R M O'Doherty
Journal:  Diabetologia       Date:  2007-12-01       Impact factor: 10.122

Review 9.  Heparan Sulfate Proteoglycan Metabolism and the Fate of Grafted Tissues.

Authors:  Jeffrey L Platt; Lucile E Wrenshall; Geoffrey B Johnson; Marilia Cascalho
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

10.  Effects of exercise on weight loss and monocytes in obese mice.

Authors:  Katie C Carpenter; Kelley Strohacker; Whitney L Breslin; Thomas W Lowder; Nadia H Agha; Brian K McFarlin
Journal:  Comp Med       Date:  2012-02       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.